DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Demser is a drug marketed by Bausch and is included in one NDA.
The generic ingredient in DEMSER is metyrosine. There are two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the metyrosine profile page.
A generic version of DEMSER was approved as metyrosine by AMNEAL on July 24th, 2020.
Recent Clinical Trials for DEMSER
Identify potential brand extensions & 505(b)(2) entrants
|Valeant Pharmaceuticals International, Inc.||Phase 2|
|Vanderbilt University Medical Center||Phase 3|
|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)||Phase 2|
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Bausch||DEMSER||metyrosine||CAPSULE;ORAL||017871-001||Approved Prior to Jan 1, 1982||AB||RX||Yes||Yes||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|